Ustekinumab for type 1 diabetes in adolescents: a multicenter, double-blind, randomized phase 2 trial
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
1 Online-Ressource.
- Sprache
-
Englisch
- Erschienen in
-
Ustekinumab for type 1 diabetes in adolescents: a multicenter, double-blind, randomized phase 2 trial ; volume:30 ; number:9 ; day:30 ; month:7 ; year:2024 ; pages:2657-2666 ; date:9.2024
Nature medicine ; 30, Heft 9 (30.7.2024), 2657-2666, 9.2024
- Urheber
-
Tatovic, Danijela
Marwaha, Ashish
Taylor, Peter
Hanna, Stephanie J.
Carter, Kym
Cheung, W. Y.
Luzio, Steve
Dunseath, Gareth
Hutchings, Hayley A.
Holland, Gail
Hiles, Steve
Fegan, Greg
Williams, Evangelia
Yang, Jennie H. M.
Domingo-Vila, Clara
Pollock, Emily
Wadud, Muntaha
Ward-Hartstonge, Kirsten
Marques-Jones, Susie
Bowen-Morris, Jane
Stenson, Rachel
Levings, Megan K.
Gregory, John W.
Tree, Timothy I. M.
Dayan, Colin
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1038/s41591-024-03115-2
- URN
-
urn:nbn:de:101:1-2411292112209.372194552801
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:40 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Tatovic, Danijela
- Marwaha, Ashish
- Taylor, Peter
- Hanna, Stephanie J.
- Carter, Kym
- Cheung, W. Y.
- Luzio, Steve
- Dunseath, Gareth
- Hutchings, Hayley A.
- Holland, Gail
- Hiles, Steve
- Fegan, Greg
- Williams, Evangelia
- Yang, Jennie H. M.
- Domingo-Vila, Clara
- Pollock, Emily
- Wadud, Muntaha
- Ward-Hartstonge, Kirsten
- Marques-Jones, Susie
- Bowen-Morris, Jane
- Stenson, Rachel
- Levings, Megan K.
- Gregory, John W.
- Tree, Timothy I. M.
- Dayan, Colin
- SpringerLink (Online service)
Ähnliche Objekte (12)
Editorial: Single-blind or double-blind review processes?
Hyperbaric treatment for children with autism: a multicenter, randomized, double-blind, controlled trial
Protocol: dexmedetomidine on myocardial injury after noncardiac surgery—a multicenter, double-blind, controlled trial
A double-blind placebo needle for acupuncture research
Treatment of migraines with Tianshu capsule: a multi-center, double-blind, randomized, placebo-controlled clinical trial
Frovatriptan versus zolmitriptan for the acute treatment of migraine: a double-blind, randomized, multicenter, Italian study
Treatment of COVID-19-associated ARDS with mesenchymal stromal cells: a multicenter randomized double-blind trial
A double-blind, randomized, multicenter, Italian study of frovatriptan versus almotriptan for the acute treatment of migraine
Frovatriptan vs almotriptan for treatment of menstrual migraine: a double-blind, randomized, cross-over, multicenter Italian study
The use of oral sildenafil citrate in hemodialysis patients: A multi-center double-blind placebo-controlled study
A double-blind, randomized, multicenter, Italian study of frovatriptan versus rizatriptan for the acute treatment of migraine
Botulinum toxin type A in post-stroke lower limb spasticity: a multicenter, double-blind, placebo-controlled trial
Editorial: Single-blind or double-blind review processes?
Hyperbaric treatment for children with autism: a multicenter, randomized, double-blind, controlled trial
Protocol: dexmedetomidine on myocardial injury after noncardiac surgery—a multicenter, double-blind, controlled trial
A double-blind placebo needle for acupuncture research
Treatment of migraines with Tianshu capsule: a multi-center, double-blind, randomized, placebo-controlled clinical trial
Frovatriptan versus zolmitriptan for the acute treatment of migraine: a double-blind, randomized, multicenter, Italian study
Treatment of COVID-19-associated ARDS with mesenchymal stromal cells: a multicenter randomized double-blind trial
A double-blind, randomized, multicenter, Italian study of frovatriptan versus almotriptan for the acute treatment of migraine
Frovatriptan vs almotriptan for treatment of menstrual migraine: a double-blind, randomized, cross-over, multicenter Italian study
The use of oral sildenafil citrate in hemodialysis patients: A multi-center double-blind placebo-controlled study
A double-blind, randomized, multicenter, Italian study of frovatriptan versus rizatriptan for the acute treatment of migraine
Botulinum toxin type A in post-stroke lower limb spasticity: a multicenter, double-blind, placebo-controlled trial
Editorial: Single-blind or double-blind review processes?
Hyperbaric treatment for children with autism: a multicenter, randomized, double-blind, controlled trial
Protocol: dexmedetomidine on myocardial injury after noncardiac surgery—a multicenter, double-blind, controlled trial
A double-blind placebo needle for acupuncture research
Treatment of migraines with Tianshu capsule: a multi-center, double-blind, randomized, placebo-controlled clinical trial
Frovatriptan versus zolmitriptan for the acute treatment of migraine: a double-blind, randomized, multicenter, Italian study
Treatment of COVID-19-associated ARDS with mesenchymal stromal cells: a multicenter randomized double-blind trial
A double-blind, randomized, multicenter, Italian study of frovatriptan versus almotriptan for the acute treatment of migraine
Frovatriptan vs almotriptan for treatment of menstrual migraine: a double-blind, randomized, cross-over, multicenter Italian study
The use of oral sildenafil citrate in hemodialysis patients: A multi-center double-blind placebo-controlled study
A double-blind, randomized, multicenter, Italian study of frovatriptan versus rizatriptan for the acute treatment of migraine